Technology Topic
Biotechnology Patent Classification
Genetic engineering classifies in C12N: microorganisms, enzymes, vectors and the mutation or genetic-engineering processes that include CRISPR-based editing.
The diagnostic side, assays that measure or test with nucleic acids, from PCR tests to sequencing chemistry, sits in C12Q.
The classification codes that matter
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING…
Microorganisms and genetic engineering: vectors, cell lines and gene-editing processes including CRISPR.
2018 → 2023: 59,302 → 68,426 filings (+15 %)
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS;…
Nucleic-acid diagnostics: PCR, sequencing assays and molecular testing.
2018 → 2023: 25,175 → 25,006 filings (-1 %)
Who files here: top applicants
- 1 CHINESE ACADEMY OF SCIENCES 10,330
- 2 HARVARD UNIVERSITY (US) 7,308
- 3 UNIVERSITY OF CALIFORNIA (US) 6,383
- 4 JIANGNAN UNIVERSITY 5,144
- 5 MONSANTO TECHNOLOGY (US) 4,121
IPC filings 2013–2023, aggregated across the codes above. Source: EPO PATSTAT.
Not sure which code fits?
Describe your technology in plain language and get matching IPC and CPC codes: